[Benign Prostatic Syndrome (BPS). Ablative Treatments]

Overview

Journal Urologe A

Specialty Urology

Date 2006 Jun 22

PMID 16788796

Citations 6

Authors

O Reich

M Seitz

C Gratzke

B Schlenker

A Bachmann

C Stief

Affiliations

Soon will be listed here.

Abstract

Today, the surgical treatment of the benign prostatic syndrome (BPS) often follows a course of drug treatment. Besides conventional transurethral resection of the prostate (TURP), which has represented the standard therapeutic option for decades, and its in part significant modifications ("vaporizing resection"; bipolar resection), much of the interest has shifted to alternative instrumental procedures like transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA) or several laser techniques. By reviewing the current literature, preferably from randomized controlled trials, these different procedures are critically assessed. Moreover, the present role of open prostatectomy is discussed.

Citing Articles

Transurethral 1470 nm diode laser vaporization versus plasma kinetic enucleation of the prostate for the treatment of benign prostatic hyperplasia: A retrospective study.

Huang J, Fan Y, Wang K, Ding H, Mao D, Zhao L Medicine (Baltimore). 2023; 102(34):e35031.

PMID: 37653733 PMC: 10470672. DOI: 10.1097/MD.0000000000035031.

Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study.

Mithani M, Khalid S, Khan S, Sharif I, Awan A, Mithani S Investig Clin Urol. 2018; 59(6):392-398.

PMID: 30402572 PMC: 6215781. DOI: 10.4111/icu.2018.59.6.392.

Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.

Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C Lasers Med Sci. 2008; 24(3):419-24.

PMID: 18685885 DOI: 10.1007/s10103-008-0591-x.

[Transurethral enucleation of the prostate with the holmium: YAG laser system: how much power is necessary?].

Rassweiler J, Roder M, Schulze M, Muschter R Urologe A. 2008; 47(4):441-8.

PMID: 18338152 DOI: 10.1007/s00120-008-1684-7.

High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates.

Seitz M, Reich O, Gratzke C, Schlenker B, Karl A, Bader M Lasers Med Sci. 2008; 24(2):172-8.

PMID: 18270761 DOI: 10.1007/s10103-008-0543-5.

References

Bachmann A, Schurch L, Ruszat R, Wyler S, Seifert H, Muller A . Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005; 48(6):965-71. DOI: 10.1016/j.eururo.2005.07.001. View

Sotelo R, Spaliviero M, Garcia-Segui A, Hasan W, Novoa J, Desai M . Laparoscopic retropubic simple prostatectomy. J Urol. 2005; 173(3):757-60. DOI: 10.1097/01.ju.0000152651.27143.b0. View

Naslund M, Carlson A, WILLIAMS M . A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period. J Urol. 2005; 173(6):2090-3. DOI: 10.1097/01.ju.0000158451.30419.66. View

Reich O, Corvin S, Oberneder R, Sroka R, Muschter R, Hofstetter A . In vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP), and vaporization-resection of the prostate (TUVRP). Urol Res. 2002; 30(1):15-20. DOI: 10.1007/s00240-001-0231-4. View

Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C . Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004; 171(6 Pt 1):2336-40. DOI: 10.1097/01.ju.0000127761.87421.a0. View

Zwergel U, Wullich B, Lindenmeir U, Rohde V, Zwergel T . Long-term results following transurethral resection of the prostate. Eur Urol. 1998; 33(5):476-80. DOI: 10.1159/000019638. View

Adam C, Hofstetter A, Deubner J, Zaak D, Weitkunat R, Seitz M . Retropubic transvesical prostatectomy for significant prostatic enlargement must remain a standard part of urology training. Scand J Urol Nephrol. 2005; 38(6):472-6. DOI: 10.1080/00365590410015858. View

Zlotta A, Giannakopoulos X, Maehlum O, Ostrem T, Schulman C . Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol. 2003; 44(1):89-93. DOI: 10.1016/s0302-2838(03)00218-5. View

Tan A, Gilling P, Kennett K, Frampton C, Westenberg A, Fraundorfer M . A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003; 170(4 Pt 1):1270-4. DOI: 10.1097/01.ju.0000086948.55973.00. View

10.

De Sio M, Autorino R, Quarto G, Damiano R, Perdona S, Di Lorenzo G . Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial. Urology. 2006; 67(1):69-72. DOI: 10.1016/j.urology.2005.07.033. View

11.

Bachmann A, Ruszat R, Wyler S, Reich O, Seifert H, Muller A . Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005; 47(6):798-804. DOI: 10.1016/j.eururo.2005.02.003. View

12.

Talic R, El Tiraifi A, El Faqih S, Hassan S, Attassi R . Prospective randomized study of transurethral vaporization resection of the prostate using the thick loop and standard transurethral prostatectomy. Urology. 2000; 55(6):886-90; discussion 890-1. DOI: 10.1016/s0090-4295(00)00520-3. View

13.

Yang Q, Peters T, Donovan J, Wilt T, Abrams P . Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2001; 165(5):1526-32. View

14.

Holman C, Wisniewski Z, Semmens J, Rouse I, Bass A . Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia. BJU Int. 1999; 84(1):37-42. DOI: 10.1046/j.1464-410x.1999.00123.x. View

15.

Mariano M, Tefilli M, Graziottin T, Morales C, Goldraich I . Laparoscopic prostatectomy for benign prostatic hyperplasia--a six-year experience. Eur Urol. 2005; 49(1):127-31. DOI: 10.1016/j.eururo.2005.09.018. View

16.

Berges R, Dreikorn K, Hofner K, Jonas U, Laval K, Madersbacher S . [Guidelines of German urologists on therapy of benign prostate syndrome]. Urologe A. 2003; 42(5):722-38. DOI: 10.1007/s00120-003-0318-3. View

17.

Thomas A, Cannon A, Bartlett E, Ellis-Jones J, Abrams P . The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. 2005; 174(5):1887-91. DOI: 10.1097/01.ju.0000176740.76061.24. View

18.

Tefekli A, Muslumanoglu A, Baykal M, Binbay M, Tas A, Altunrende F . A hybrid technique using bipolar energy in transurethral prostate surgery: a prospective, randomized comparison. J Urol. 2005; 174(4 Pt 1):1339-43. DOI: 10.1097/01.ju.0000173075.62504.73. View

19.

Dunsmuir W, McFarlane J, Tan A, Dowling C, Downie J, Kourambas J . Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate Cancer Prostatic Dis. 2003; 6(2):182-6. DOI: 10.1038/sj.pcan.4500631. View

20.

Daehlin L, Frugard J . Transurethral microwave thermotherapy in the management of lower urinary tract symptoms from benign prostatic obstruction: follow-up after five years. Scand J Urol Nephrol. 2001; 34(5):304-8. DOI: 10.1080/003655900750048314. View